EnMed Collaboration Addresses Shortage of Inhaler Device to Help COVID-19 Patients | Houston Methodist
![Sterilization plan of the used metered dose inhalers (MDI) to avoid wastage amid COVID-19 pandemic drug shortage | Journal of Pharmaceutical Policy and Practice | Full Text Sterilization plan of the used metered dose inhalers (MDI) to avoid wastage amid COVID-19 pandemic drug shortage | Journal of Pharmaceutical Policy and Practice | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40545-020-00224-4/MediaObjects/40545_2020_224_Fig1_HTML.png)
Sterilization plan of the used metered dose inhalers (MDI) to avoid wastage amid COVID-19 pandemic drug shortage | Journal of Pharmaceutical Policy and Practice | Full Text
![Inhalable COVID-19 vaccine could expand the reach of COVID-19 vaccines around the world - Northeastern Global News Inhalable COVID-19 vaccine could expand the reach of COVID-19 vaccines around the world - Northeastern Global News](https://news.northeastern.edu/wp-content/uploads/2021/07/071921_AS_Inhaler01-1.jpg)
Inhalable COVID-19 vaccine could expand the reach of COVID-19 vaccines around the world - Northeastern Global News
![Managing adult asthma during the COVID-19 pandemic: A 2022 review and current recommendations - Annals Singapore Managing adult asthma during the COVID-19 pandemic: A 2022 review and current recommendations - Annals Singapore](https://annals.edu.sg/wp-content/uploads/2022/10/inhaler-article-1024x801.jpg?x62182)
Managing adult asthma during the COVID-19 pandemic: A 2022 review and current recommendations - Annals Singapore
![A message to asthma sufferers about a shortage of albuterol metered dose inhalers - ACAAI Public Website A message to asthma sufferers about a shortage of albuterol metered dose inhalers - ACAAI Public Website](https://acaai.org/wp-content/uploads/2021/05/Albuterol2-1000x1000-1-300x300.jpg)
A message to asthma sufferers about a shortage of albuterol metered dose inhalers - ACAAI Public Website
![Common asthma treatment reduces need for hospitalisation in COVID-19 patients, study suggests | University of Oxford Common asthma treatment reduces need for hospitalisation in COVID-19 patients, study suggests | University of Oxford](https://www.ox.ac.uk/sites/files/oxford/styles/ow_medium_feature/s3/field/field_image_main/Virus%20banner_0.jpg?itok=DlVvXAe-)
Common asthma treatment reduces need for hospitalisation in COVID-19 patients, study suggests | University of Oxford
![Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial - The Lancet Respiratory Medicine Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/attachment/c8a53fd8-7246-40de-acd7-9d497f8dee0c/gr1_lrg.gif)
Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial - The Lancet Respiratory Medicine
![Inhaled steroids to be tested as a possible treatment for COVID-19 as part of PRINCIPLE trial | NIHR Inhaled steroids to be tested as a possible treatment for COVID-19 as part of PRINCIPLE trial | NIHR](https://www.nihr.ac.uk/images/news/PRINCIPLE-inhaler-budesonide.png)
Inhaled steroids to be tested as a possible treatment for COVID-19 as part of PRINCIPLE trial | NIHR
![Asthma and coronavirus: Inhalers in short supply during COVID-19 crisis, Premier Allergy, Asthma and Sinus Care's Dr. John Latall says - ABC7 Chicago Asthma and coronavirus: Inhalers in short supply during COVID-19 crisis, Premier Allergy, Asthma and Sinus Care's Dr. John Latall says - ABC7 Chicago](https://cdn.abcotvs.com/dip/images/6129219_042520-wls-asthma-drugs-8a-img.jpg?w=1600)
Asthma and coronavirus: Inhalers in short supply during COVID-19 crisis, Premier Allergy, Asthma and Sinus Care's Dr. John Latall says - ABC7 Chicago
![Blood type not a COVID-19 risk factor in U.S.; inhaled asthma drug may keep mild illness from worsening | Reuters Blood type not a COVID-19 risk factor in U.S.; inhaled asthma drug may keep mild illness from worsening | Reuters](https://cloudfront-us-east-2.images.arcpublishing.com/reuters/BS7QQSHMJVKBZDU4EBZARCPHZA.jpg)
Blood type not a COVID-19 risk factor in U.S.; inhaled asthma drug may keep mild illness from worsening | Reuters
![Asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19 | University of Oxford Asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19 | University of Oxford](https://www.ox.ac.uk/sites/files/oxford/styles/ow_medium_feature/s3/field/field_image_main/thumbnail_BUDESONIDE_COMPOSITE.jpg?itok=5_9Ln01t)